Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial

Bibliographic Details
Main Authors: Wechsler, M, Akuthota, P, Jayne, D, Khoury, P, Klion, A, Langford, C, Merkel, P, Moosig, F, Specks, U, Cid, M, Luqmani, R, Brown, J, Mallett, S, Philipson, R, Yancey, S, Steinfeld, J, Weller, P, Gleich, G
Format: Conference item
Published: American Thoracic Society 2017
_version_ 1826298011430420480
author Wechsler, M
Akuthota, P
Jayne, D
Khoury, P
Klion, A
Langford, C
Merkel, P
Moosig, F
Specks, U
Cid, M
Luqmani, R
Brown, J
Mallett, S
Philipson, R
Yancey, S
Steinfeld, J
Weller, P
Gleich, G
author_facet Wechsler, M
Akuthota, P
Jayne, D
Khoury, P
Klion, A
Langford, C
Merkel, P
Moosig, F
Specks, U
Cid, M
Luqmani, R
Brown, J
Mallett, S
Philipson, R
Yancey, S
Steinfeld, J
Weller, P
Gleich, G
author_sort Wechsler, M
collection OXFORD
description
first_indexed 2024-03-07T04:40:19Z
format Conference item
id oxford-uuid:d1667d04-849c-4e17-9a82-2fd82ffd7ab9
institution University of Oxford
last_indexed 2024-03-07T04:40:19Z
publishDate 2017
publisher American Thoracic Society
record_format dspace
spelling oxford-uuid:d1667d04-849c-4e17-9a82-2fd82ffd7ab92022-03-27T07:56:47ZMepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled TrialConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:d1667d04-849c-4e17-9a82-2fd82ffd7ab9Symplectic Elements at OxfordAmerican Thoracic Society2017Wechsler, MAkuthota, PJayne, DKhoury, PKlion, ALangford, CMerkel, PMoosig, FSpecks, UCid, MLuqmani, RBrown, JMallett, SPhilipson, RYancey, SSteinfeld, JWeller, PGleich, G
spellingShingle Wechsler, M
Akuthota, P
Jayne, D
Khoury, P
Klion, A
Langford, C
Merkel, P
Moosig, F
Specks, U
Cid, M
Luqmani, R
Brown, J
Mallett, S
Philipson, R
Yancey, S
Steinfeld, J
Weller, P
Gleich, G
Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial
title Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial
title_full Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial
title_fullStr Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial
title_full_unstemmed Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial
title_short Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial
title_sort mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis a phase iii randomized placebo controlled trial
work_keys_str_mv AT wechslerm mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT akuthotap mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT jayned mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT khouryp mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT kliona mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT langfordc mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT merkelp mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT moosigf mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT specksu mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT cidm mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT luqmanir mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT brownj mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT malletts mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT philipsonr mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT yanceys mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT steinfeldj mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT wellerp mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial
AT gleichg mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomizedplacebocontrolledtrial